Insider Transactions in Q4 2022 at Bellerophon Therapeutics, Inc. (BLPH)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Dec 09 2022	Peter Fernandes Officer	SELL Payment of exercise price or tax liability	Direct	9,985 -30.72%	$0 $0.93 P/Share
Dec 09 2022	Peter Fernandes Officer	BUY Exercise of conversion of derivative security	Direct	32,500 +50.0%	-
Dec 09 2022	Nicholas Laccona FINANCIAL OFFICER, (PFO & PAO)	SELL Payment of exercise price or tax liability	Direct	5,530 -30.72%	$0 $0.93 P/Share
Dec 09 2022	Nicholas Laccona FINANCIAL OFFICER, (PFO & PAO)	BUY Exercise of conversion of derivative security	Direct	18,000 +50.0%	-
Dec 09 2022	Parag Suresh Shah VP of Business Operations	SELL Payment of exercise price or tax liability	Direct	7,834 -30.72%	$0 $0.93 P/Share
Dec 09 2022	Parag Suresh Shah VP of Business Operations	BUY Exercise of conversion of derivative security	Direct	25,500 +50.0%	-
Dec 09 2022	Martin Dekker Officer	SELL Payment of exercise price or tax liability	Direct	7,834 -30.72%	$0 $0.93 P/Share
Dec 09 2022	Martin Dekker Officer	BUY Exercise of conversion of derivative security	Direct	25,500 +50.0%	-

Receive a notification when an Institution or Guru buys or sells BLPH shares.

Notify only if

Value

Get notified when an Bellerophon Therapeutics, Inc. insider buys or sells BLPH shares.

Notify only if

Operation

Value

Type

Receive news related to Bellerophon Therapeutics, Inc.